Gitte Moos Knudsen, Prof., MD, DMSc

Chief Neurologist at Rigshospitalet, Copenhagen Professor of Clinical Neurobiology at Copenhagen University Director of the Center for Experimental Medicine Neuropharmacology (NeuroPharm) President of European College of Neuropsychopharmacology


Gitte Moos Knudsen, Professor, Chief Neurologist, DMSc, Neurobiology Research Unit (NRU), Rigshospitalet and University of Copenhagen (UCPH), Denmark.

Director of the Lundbeck Foundation Cimbi (2006-17), Innovation Fund Center NeuroPharm (2016-).

Present appointments: Chief neurologist at Dept Neurology and chairman at the Neurobiology Research Unit (NRU), Rigshospitalet, and Director of Center for Experimental Medicine Neuropharmacology (NeuroPharm). Professor in Clinical Neurobiology at the Univ. Copenhagen. President of the European College of Neuropsychopharmacology.

Research focus: I am a translational neurobiologist and clinical neurologist with interest in advanced methodological developments that I subsequently apply in my research to address pertinent neurobiological and clinical issues. I have a particular focus on multimodality neuroimaging of pharmacological effects in large animals, in healthy individuals and in patients with brain disorders.


Why do the effects of some psychedelics last 10 hours, while others are over within minutes? Gitte Moos Knudsen is a translational neurobiologist and clinical neurologist with a large track record of research into serotonin 2A receptors. She will speak at ICPR on the reasons for long- or short-acting psychedelics, the future development of possible specific psychedelics, and what this will mean for future research and development.

Other Speakers at ICPR 2022

Founder and Executive Director at MAPS, the Multidisciplinary Association for Psychedelic Studies, United States

Associate Professor at Faculty of Psychology and Neuroscience at Maastricht University, The Netherlands

Founder of Fungi Perfecti and CEO of MycoMedica Life Sciences PBC, United States

Ready To Attend ICPR 2022?​

Join the leading conference in Europe dedicated to advancing psychedelic research and therapies.

About ICPR

The Interdisciplinary Conference on Psychedelic Research (ICPR) is Europe’s leading academic conference dedicated to advancing psychedelic research and therapies organised by the OPEN Foundation since 2010. ICPR is a biennial conference focused on high-quality scientific and scholarly research into psychedelics. ICPR 2022 is our fifth event. After our hugely successful online conference in 2020, we are returning to the prestigious Philharmonie Theatre for an in-person event! ICPR will take place in Haarlem (next to Amsterdam) from September 22nd to 24th, 2022.